Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Molecular dynamics study of nanoconfined TIP4P/2005 water: how confinement and temperature affect diffusion and viscosity.

Zaragoza A, Gonzalez MA, Joly L, López-Montero I, Canales MA, Benavides AL, Valeriani C.

Phys Chem Chem Phys. 2019 Jul 7;21(25):13653-13667. doi: 10.1039/c9cp02485a. Epub 2019 Jun 13.

PMID:
31190039
2.

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.

Hiddemann W, Barbui AM, Canales MA, Cannell PK, Collins GP, Dürig J, Forstpointner R, Herold M, Hertzberg M, Klanova M, Radford J, Seymour JF, Tobinai K, Trotman J, Burciu A, Fingerle-Rowson G, Wolbers M, Nielsen T, Marcus RE.

J Clin Oncol. 2018 Aug 10;36(23):2395-2404. doi: 10.1200/JCO.2017.76.8960. Epub 2018 Jun 1.

PMID:
29856692
3.

A 60-Year-Old Male Smoker With Chronic Obstructive Pulmonary Disease and Hypereosinophilia.

Sánchez-Jareño M, Yuste Jiménez V, Villasante C, Canales MÁ, Álvarez-Sala R.

Arch Bronconeumol. 2018 Jan 17. pii: S0300-2896(17)30440-4. doi: 10.1016/j.arbres.2017.11.016. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29361319
4.

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.

González-Barca E, Canales MA, Salar A, Ferrer S, Domingo-Domenech E, Vidal MJ, Grande C, Bargay J, Gardella S, Oriol A, Briones J, García-Frade J, Bello JL, Sánchez-Blanco JJ, Peñalver FJ, Tomás JF, Asensio A, López A, Caballero D; GELTAMO Group (Grupo Español de Linfoma y Trasplante de Médula Ósea).

Acta Haematol. 2016;136(2):76-84. doi: 10.1159/000444625. Epub 2016 May 18.

PMID:
27188649
5.

Insights into the C-terminal Peptide Binding Specificity of the PDZ Domain of Neuronal Nitric-oxide Synthase: CHARACTERIZATION OF THE INTERACTION WITH THE TIGHT JUNCTION PROTEIN CLAUDIN-3.

Merino-Gracia J, Costas-Insua C, Canales MÁ, Rodríguez-Crespo I.

J Biol Chem. 2016 May 27;291(22):11581-95. doi: 10.1074/jbc.M116.724427. Epub 2016 Mar 30.

6.

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

Briones J, Novelli S, García-Marco JA, Tomás JF, Bernal T, Grande C, Canales MA, Torres A, Moraleda JM, Panizo C, Jarque I, Palmero F, Hernández M, González-Barca E, López D, Caballero D; Grupo Español de Linfomas y Trasplante Autologo de Médula Ósea (GELTAMO).

Haematologica. 2014 Jul;99(7):e126. doi: 10.3324/haematol.2014.108308. No abstract available.

7.

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.

Briones J, Novelli S, García-Marco JA, Tomás JF, Bernal T, Grande C, Canales MA, Torres A, Moraleda JM, Panizo C, Jarque I, Palmero F, Hernández M, González-Barca E, López D, Caballero D; GELTAMO.

Haematologica. 2014 Mar;99(3):505-10. doi: 10.3324/haematol.2013.093450. Epub 2013 Oct 25.

8.

First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group.

Arranz R, García-Noblejas A, Grande C, Cannata-Ortiz J, Sánchez JJ, García-Marco JA, Aláez C, Pérez-Calvo J, Martínez-Sánchez P, Sánchez-González B, Canales MA, Conde E, Martín A, Arranz E, Terol MJ, Salar A, Caballero D.

Haematologica. 2013 Oct;98(10):1563-70. doi: 10.3324/haematol.2013.088377. Epub 2013 Jun 10.

9.

Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group.

Caballero D, Campo E, López-Guillermo A, Martín A, Arranz-Sáez R, Giné E, López A, González-Barca E, Canales MÁ, González-Díaz M, Orfao A.

Ann Hematol. 2013 Sep;92(9):1151-79. doi: 10.1007/s00277-013-1783-4. Epub 2013 May 29. Review.

PMID:
23716187
10.

[Septic arthritis due to Escherichia coli in a patient with multiple myeloma and left knee pain].

Romero Fernández E, Hernández-Maraver D, Canales MÁ, Rodríguez de la Rúa A.

Reumatol Clin. 2011 Mar-Apr;7(2):149-50. doi: 10.1016/j.reuma.2010.06.005. Epub 2011 Feb 4. Spanish. No abstract available.

11.

Characterization of SMG-9, an essential component of the nonsense-mediated mRNA decay SMG1C complex.

Fernández IS, Yamashita A, Arias-Palomo E, Bamba Y, Bartolomé RA, Canales MA, Teixidó J, Ohno S, Llorca O.

Nucleic Acids Res. 2011 Jan;39(1):347-58. doi: 10.1093/nar/gkq749. Epub 2010 Sep 3.

12.

Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications.

Garcia V, Garcia JM, Silva J, Martin P, Peña C, Dominguez G, Diaz R, Herrera M, Maximiano C, Sabin P, Rueda A, Cruz MA, Rodriguez J, Canales MA, Bonilla F, Provencio M.

PLoS One. 2009 Dec 15;4(12):e8173. doi: 10.1371/journal.pone.0008173.

13.

[Doxorubicin-induced cardiotoxicity: are there effective alternatives for prevention?].

Canales MA.

Med Clin (Barc). 2010 Jan 30;134(2):70-1. doi: 10.1016/j.medcli.2009.09.020. Epub 2009 Nov 6. Spanish. No abstract available.

PMID:
19896152
14.

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.

Salar A, Domingo-Domenech E, Estany C, Canales MA, Gallardo F, Servitje O, Fraile G, Montalbán C.

Cancer. 2009 Nov 15;115(22):5210-7. doi: 10.1002/cncr.24605.

15.

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.

Martín A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, Andreu R, Salar A, García-Sanchez P, Vázquez L, Nistal S, Requena MJ, Donato EM, González JA, León A, Ruiz C, Grande C, González-Barca E, Caballero MD; Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Cooperative Group).

Haematologica. 2008 Dec;93(12):1829-36. doi: 10.3324/haematol.13440. Epub 2008 Oct 22.

16.

Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain.

Sancho JM, Morgades M, Alonso N, Deben G, Fernández de Sevilla A, Vázquez L, Nicolás C, García Vela JA, Arranz R, Abella E, Canales MA, Miralles P, Sánchez E, Hermosilla M, Conde E, Rueda A, Ribera JM; investigators of QUIT Study (PETHEMA, GELTAMO and GOTEL Groups).

Med Clin (Barc). 2008 Oct 11;131(12):441-6.

PMID:
18928733
17.

Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?

Garcia-Rodriguez MJ, Canales MA, Hernandez-Maraver D, Hernandez-Navarro F.

Am J Hematol. 2008 Aug;83(8):673-5. doi: 10.1002/ajh.21214.

18.

Nutritional recommendations in hematopoietic stem cell transplantation.

Martin-Salces M, de Paz R, Canales MA, Mesejo A, Hernandez-Navarro F.

Nutrition. 2008 Jul-Aug;24(7-8):769-75. doi: 10.1016/j.nut.2008.02.021. Epub 2008 May 12. Review.

PMID:
18468863
19.

Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab.

Martin-Salces M, Canales MA, de Paz R, Hernandez-Navarro F.

Leuk Res. 2008 Jan;32(1):199-200. Epub 2007 Sep 17. No abstract available.

PMID:
17870157
20.

[Oral cobalamin therapy: a note of caution].

Canales MA, de Paz R, Hernández Navarro F.

Med Clin (Barc). 2007 May 19;128(19):757. Spanish. No abstract available.

PMID:
17565886
21.

Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too.

Canales MA, Martin A, Caballero D, Hernandez-Navarro F.

Br J Haematol. 2006 Sep;134(6):645-6. Epub 2006 Aug 1. No abstract available.

PMID:
16889614
22.

[Megaloblastic anemia].

de Paz R, Canales MA, Hernández-Navarro F.

Med Clin (Barc). 2006 Jul 1;127(5):185-8. Spanish. No abstract available.

PMID:
16834955
23.

[Histiocytic sarcoma: case report with atypical onset].

de Paz R, Canales MA, Morado M, Hernández-Navarro F.

Med Clin (Barc). 2005 May 28;124(20):798-9. Spanish. No abstract available.

PMID:
15927113
24.

[Observations on the etiologic relationship of achylia gastrica to pernicious anemia. X. Activity of vitamin B12 food (extrinsic) factor].

de Paz Arias R, Canales MA, Hernández-Navarro F.

Nutr Hosp. 2004 Nov-Dec;19(6):383-6. Spanish. No abstract available.

PMID:
15672656
25.

G-CSF or not G-CSF? That is the question.

Canales MA, Hernández-Navarro F.

Bone Marrow Transplant. 2004 Sep;34(6):557. No abstract available.

PMID:
15286698
26.

Granulocytic sarcoma (chloroma) of the lung.

de Paz R, Canales MA, Hernandez-Navarro F.

Br J Haematol. 2003 Jan;120(2):176. No abstract available.

PMID:
12542473
27.

Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors.

Canales MA, Arrieta R, Gomez-Rioja R, Diez J, Jimenez-Yuste V, Hernandez-Navarro F.

J Hematother Stem Cell Res. 2002 Aug;11(4):675-81.

PMID:
12201956
28.

Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: Case report and review of the literature.

Delgado J, Canales MA, Garcia B, Alvarez-Ferreira J, Garcia-Grande A, Hernandez-Navarro F.

Am J Hematol. 2002 Feb;69(2):127-31. Review.

29.

NMR investigations of protein-carbohydrate interactions: insights into the topology of the bound conformation of a lactose isomer and beta-galactosyl xyloses to mistletoe lectin and galectin-1.

Alonso-Plaza JM, Canales MA, Jiménez M, Roldán JL, García-Herrero A, Iturrino L, Asensio JL, Cañada FJ, Romero A, Siebert HC, André S, Solís D, Gabius HJ, Jiménez-Barbero J.

Biochim Biophys Acta. 2001 Dec 19;1568(3):225-36.

PMID:
11786229
30.

A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation.

De Ferrari GV, Canales MA, Shin I, Weiner LM, Silman I, Inestrosa NC.

Biochemistry. 2001 Sep 4;40(35):10447-57.

PMID:
11523986
31.

Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease.

Canales MA, Fernández-Jiménez MC, Martín A, Arrieta R, Caballero MD, Díez J, Quevedo E, García-Bustos J, San Miguel JF, Hernández-Navarro F.

Haematologica. 2001 May;86(5):494-8.

32.

Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.

Martín A, Fernández-Jiménez MC, Caballero MD, Canales MA, Pérez-Simón JA, García de Bustos J, Vázquez L, Hernández-Navarro F, San Miguel JF.

Br J Haematol. 2001 Apr;113(1):161-71.

PMID:
11328296
33.

[Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].

Canales MA, Martínez J, Quevedo E, Hernández-Navarro F.

Sangre (Barc). 1999 Dec;44(6):493-4. Spanish. No abstract available.

PMID:
10822770
34.

[Cryopreservation of hematopoietic progenitor cells].

Canales MA, Arrieta R, Hernández Navarro F.

Sangre (Barc). 1999 Dec;44(6):473-81. Review. Spanish. No abstract available.

PMID:
10822763
35.

Factors influencing collection and engraftment of CD34+ cells in patients with breast cancer following high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation.

Canales MA, Arrieta R, Hernández-García MC, Ojeda E, Díez J, Calero F, Aguado MJ, Bustos JG, Hernández-Navarro F.

J Hematother Stem Cell Res. 2000 Feb;9(1):103-9.

PMID:
10738978
36.

Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.

Fernández-Jiménez MC, Canales MA, Ojeda E, de Bustos JG, Aguado MJ, Hernández-Navarro F.

Haematologica. 1999 Nov;84(11):1007-11.

37.

Molecular modeling of the amyloid-beta-peptide using the homology to a fragment of triosephosphate isomerase that forms amyloid in vitro.

Contreras CF, Canales MA, Alvarez A, De Ferrari GV, Inestrosa NC.

Protein Eng. 1999 Nov;12(11):959-66.

PMID:
10585501
38.

[Efficacy of the combined treatment with immunoglobulins and plasmapheresis in a pregnant woman with Rh alloimmunization and antiphospholipid antibodies].

Canales MA, Sevilla J, Hernández D, Hernández Navarro F.

Med Clin (Barc). 1999 Oct 9;113(11):438-9. Spanish. No abstract available.

PMID:
10562958
39.

A single apheresis to achieve a high number of peripheral blood CD34+ cells in a lithium-treated patient with acute myeloid leukaemia.

Canales MA, Arrieta R, Hernández-García C, Bustos JG, Aguado MJ, Hernández-Navarro F.

Bone Marrow Transplant. 1999 Feb;23(3):305. No abstract available.

40.

[Association of multiple myeloma and autoimmune hemolytic anemia].

Morado M, Canales MA, Aguado MJ, Hernández Navarro F.

Sangre (Barc). 1998 Oct;43(5):467-8. Spanish. No abstract available.

PMID:
9868350
41.

Human parvovirus B19 antibodies are less frequent among patients treated with factor IX concentrate inactivated by ultrafiltration: a report from a single Spanish institution.

Canales MA, Pinilla J, Mateos P, Martínez Zapico R, Alvarez T, Jiménez VM, Quintana M, Villar A, Hernández Navarro F, Magallón M.

Vox Sang. 1998;74(4):260-1. No abstract available.

PMID:
9691409
42.

Successful treatment of Trichosporon beigelii pneumonia with itraconazole.

Canales MA, Sevilla J, Ojeda Gutierrez E, Hernández Navarro F.

Clin Infect Dis. 1998 Apr;26(4):999-1000. No abstract available.

PMID:
9564494
43.

Asthma management: putting your patient on the team.

Canales MA.

Nursing. 1997 Dec;27(12):33-8; quiz 45. Review. No abstract available.

PMID:
9429472
44.

[Inflation of the endotracheal tube cuff as an aid for blind nasotracheal intubation in patients with predicted difficult laryngoscopy].

Casals-Caus P, Mayoral-Rojals V, Canales MA, Ruiz-Tamarit V, Casals-Castells A, Cochs-Cristià J.

Rev Esp Anestesiol Reanim. 1997 Oct;44(8):302-4. Spanish.

PMID:
9424682
45.

[The Combitube as an alternative method when intubation is impossible].

Casals P, Cochs J, Mayoral V, Rey F, Drudis R, Canales MA.

Rev Esp Anestesiol Reanim. 1994 May-Jun;41(3):189-90. Spanish. No abstract available.

PMID:
8059051

Supplemental Content

Loading ...
Support Center